re: Ann: Positive Disc Repair Results Using M... All good things happening. Great to see confirmation of Capital continuing to top up another 1% and if prices stay below $6 I would expect to see them continue.
Edison research came out with this last night:
Mesoblast has reported positive results from its 100-patient Phase II trial of mesenchymal precursor cells (MPCs) in patients with chronic moderate-to-severe discogenic low back pain. The data show strong indications of sustained efficacy across a broad range of clinical and radiographic parameters and support a planned move into Phase III studies. We maintain our recently increased valuation of A$3.0bn (A$9.06/diluted share), noting that the use of a higher probability (50%) to reflect a possible Phase III start of the two spinal programmes would increase the rNPV to A$3.2bn or A$10.04/share.
So more ticks and positive news to come. Spruik this to your friends and family, might be the best performer of the ASX200 for 2014!
Ann: Positive Disc Repair Results Using Mesoblast, page-22
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |